No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
GOSS Gossamer Bio
- 0.844
- -0.014-1.64%
Close Dec 24 13:00 ET
- 0.860
- +0.016+1.90%
Post 13:08 ET
191.23MMarket Cap-3.38P/E (TTM)
0.880High0.820Low487.09KVolume0.870Open0.858Pre Close414.10KTurnover0.26%Turnover RatioLossP/E (Static)226.60MShares1.60052wk High3.53P/B158.76MFloat Cap0.49952wk Low--Dividend TTM188.12MShs Float27.150Historical High--Div YieldTTM6.96%Amplitude0.453Historical Low0.850Avg Price1Lot Size
Post-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
After Plunging -15.92% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)
Gossamer Bio (GOSS) Gets a Buy From Oppenheimer
HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $10 Price Target
Gossamer Bio Analyst Ratings
Promising Progress and Expansion Potential of Gossamer Bio's Seralutinib Drive Buy Rating
Heat List
US
Overall
Symbol
Price
% Chg
No Data